A phase II study of cisplatin, oral administration of etoposide, OK-432 and radiation therapy for inoperable stage III non-small cell lung cancer
| Autor: | M. Yonechi, Y. Mariya, T. Akaizawa, K. Ohkuda, K. Yamada, Hiroshi Fukuda, Seiro Yoshioka, N. Maehira, Jutaro Takahashi, Shuichi Ono, T. Takahashi, Kazuo Kubota, N. Asoh, Yoshinao Abe, Masahiko Aoki |
|---|---|
| Rok vydání: | 1998 |
| Předmět: |
Oncology
Cisplatin medicine.medical_specialty business.industry medicine.medical_treatment Phases of clinical research Hematology General Medicine medicine.disease respiratory tract diseases Radiation therapy Surgical oncology Internal medicine medicine Surgery Stage (cooking) Lung cancer business Etoposide medicine.drug Cancer staging |
| Zdroj: | International Journal of Clinical Oncology. 3:365-369 |
| ISSN: | 1437-7772 1341-9625 |
| DOI: | 10.1007/bf00539214 |
| Popis: | Background. This study was designed to evaluate the feasibility and efficiency of giving cisplatin, etoposide, and OK432 concurrently with conventional radiotherapy (RTx) for patient's with inoperable stage III, based on the TNM classification according to the International Union against Cancer staging system for lung cancer (1987) non-small cell lung cancer (NSCLC). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink